Gilead tanks 9% on report its coronavirus drug doesn't help patients (GILD)

Business Insider

Published

· *Gilead stock plunged as much as 9% on Thursday after STAT News reported its experimental coronavirus drug remdesivir failed to improve patient conditions in a clinical trial.*
· *A summary of the trial's results was mistakenly uploaded to the WHO's website, STAT reported.*
· *The report contained "inappropriate...

Full Article